MUMBAI, India, Oct. 24 -- Intellectual Property India has published a patent application (202441031399 A) filed by MSN Laboratories Private Limited, R&D Center, Hyderabad, Telangana, on April 19, 2024, for 'pharmaceutical comprising rimegepant.'
Inventor(s) include Ravi Kumar Nithiyanandam; Dr. Mahesh N. Padamwar; and Dr. Sabyasachi Swain.
The application for the patent was published on Oct. 24, under issue no. 43/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to pharmaceutical comprising rimegepant or a pharmaceutically acceptable salts thereof and process for preparation which is simple, economic, cost-effective, and industrially amenable to scale up. Further, the said invent...